Jiangxi Dongfu Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Huiyinbi Pharmaceutical Joint-stock Co., Ltd. It is a pharmaceutical manufacturer mainly producing small-volume injections. Founded in May 2015, it is located in the Fuzhou National High-tech Industrial Development Zone, Jiangxi Province, covering an area of 62 mu, and is a national high-tech enterprise.
The company owns the domestically exclusive variety Tropisetron Citrate Injection, as well as 9 drug approval numbers including Lincomycin Hydrochloride Injection and Levocarnitine Injection. Among them, Tropisetron Citrate Injection is a Class IV new drug in China and has won honors such as the Jiangxi Province "New Product Certificate", "Provincial New Product Award", and "First Prize for Outstanding New Product", and its core technology has obtained 5 national invention patents.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows